What is the proper way to order Paxlovid (nirmatrelvir and ritonavir)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Order Paxlovid (Nirmatrelvir/Ritonavir)

To properly order Paxlovid, prescribe nirmatrelvir 300 mg (two 150 mg tablets) with ritonavir 100 mg (one 100 mg tablet) to be taken together orally twice daily for 5 days, initiated within 5 days of COVID-19 symptom onset. 1, 2

Patient Selection and Timing

  1. Identify eligible patients:

    • High-risk adults with mild-to-moderate COVID-19
    • Treatment must begin within 5 days of symptom onset
    • Prioritize patients at high risk for hospitalization or death 1
  2. Assess renal function:

    • Normal to mild impairment (eGFR ≥60 mL/min): Standard dose
    • Moderate impairment (eGFR 30-59 mL/min): Reduced dose of 150 mg nirmatrelvir with 100 mg ritonavir twice daily
    • Severe impairment (eGFR <30 mL/min): Day 1: 300 mg nirmatrelvir with 100 mg ritonavir once; Days 2-5: 150 mg nirmatrelvir with 100 mg ritonavir once daily 1, 2, 3
  3. Assess hepatic function:

    • Not recommended in patients with severe hepatic impairment (Child-Pugh Class C) 2

Critical Step: Drug Interaction Screening

This is the most important safety consideration when ordering Paxlovid:

  1. Review ALL medications the patient is currently taking
  2. Check for contraindicated medications that interact with ritonavir (strong CYP3A inhibitor)
  3. Use the Liverpool COVID-19 Drug Interaction Tool to identify and manage potential interactions 1
  4. Common problematic medications include:
    • Anticoagulants (particularly rivaroxaban) 4
    • Certain statins, antiarrhythmics, and sedatives
    • Medications highly dependent on CYP3A for clearance 2

Prescription Details

  1. Standard dosing:

    • Nirmatrelvir 300 mg (two 150 mg tablets) with ritonavir 100 mg (one 100 mg tablet)
    • Take all three tablets together twice daily for 5 days
    • Can be taken with or without food 2
  2. Administration instructions:

    • Take at approximately the same time each day
    • Swallow tablets whole (do not chew, break, or crush)
    • Complete the full 5-day course 1, 2

Patient Education

When ordering Paxlovid, ensure patients understand:

  1. The importance of starting treatment within 5 days of symptom onset
  2. The need to complete the full 5-day course
  3. Common side effects: dysgeusia (altered taste) and diarrhea 5
  4. The critical importance of disclosing all medications they are taking
  5. To report any serious side effects immediately

Common Pitfalls to Avoid

  • Failure to screen for drug interactions - this is the most common and potentially dangerous error
  • Not adjusting dosage for renal impairment
  • Prescribing beyond 5 days from symptom onset
  • Not completing the full treatment course
  • Not specifying the numeric dose of each active ingredient 2

Special Considerations

  • Pregnancy: Paxlovid represents an option for pregnant people with COVID-19 to reduce disease progression risk 1
  • Hemodialysis patients: Administer dose after hemodialysis 2
  • Drug interactions: May require dose adjustments, temporary discontinuation, or additional monitoring of concomitant medications 1, 2

Remember that Paxlovid has demonstrated an 89% relative risk reduction in hospitalization and death when given within 3 days of symptom onset in high-risk, unvaccinated adults 5, making proper and timely prescribing crucial for optimal patient outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.